MSL
IART icon

Mackay Shields LLC’s Integra LifeSciences IART Stock Holding History

Mackay Shields LLC’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-28,961
Closed -$1.74M – 1397
2019
Q3 		$1.74M Buy
+28,961
New +$1.73M 0.01% 952
2019
Q2 		– Sell
-18,811
Closed -$1.05M – 1456
2019
Q1 		$1.05M Buy
+18,811
New +$958K 0.01% 984

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Mackay Shields LLC's IART Position: Q4 2019 in Review

Mackay Shields LLC sold out of Integra LifeSciences (IART) in Q4 2019, closing a stake of 28,961 shares — an estimated $1.74M sold.

Mackay Shields LLC first reported a position in IART in Q1 2019 and held it in 2 quarters. The position peaked at $1.74M in Q3 2019. 279 funds tracked by Wall St. Rank hold IART as of Q4 2019.

  • Mackay Shields LLC reported no remaining Integra LifeSciences position as of Q4 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 28,961 Integra LifeSciences shares in Q4 2019, an estimated $1.74M.
  • Mackay Shields LLC first reported a position in Integra LifeSciences in Q1 2019 and held it in 2 quarters.
  • Mackay Shields LLC's Integra LifeSciences position peaked at $1.74M in Q3 2019.
  • 279 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2019.

Based on Mackay Shields LLC's 13F filing for Q4 2019, filed 11 Feb 2020.